Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F1J05
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,388
Award facts
- Contract value 100% obligated
- $29,387.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,387.93 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Cosentyx, a specialty biologic medication used primarily for autoimmune conditions, represents the type of specialized pharmaceutical commodity within the contract's scope. Through this IDC structure, AmerisourceBergen provides critical medical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program is planning Generation V contracts with potential awards to multiple regional contractors, positioning AmerisourceBergen among key strategic suppliers for federal military and veteran healthcare pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26F1J05?
SPE2DR26F1J05 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F1J05 worth?
The government has obligated $29,388 on SPE2DR26F1J05.
Is contract SPE2DR26F1J05 an order under another contract?
Yes. SPE2DR26F1J05 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1J05 competed?
The extent of competition for SPE2DR26F1J05 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award